跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Retavastatin - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Retavastatin
Approved
STANDARD
Retavastatin
Stallion Laboratories Pvt. Ltd.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
076febd1aa35b5e5
Company
Stallion Laboratories Pvt. Ltd.
Type
Standard
Approval Details
Approval Id
076febd1aa35b5e5
Drug Approval Philippines Name
Retavastatin
Product Name
Retavastatin
Registration Number
DRP-10748-03
Brand Name
Retavastatin
Generic Name
Atorvastatin (as calcium)
Dosage Form
Film-Coated Tablet
Dosage Strength
40 mg
Manufacturer
Stallion Laboratories Pvt. Ltd.
Importer
Ambica International Corporation
Distributor
Reta Drug
Issuance Date
23 September 2024
Expiry Date
15 November 2026
Pharmacologic Category
Lipid Modifying Agent (HMG CoA Reductase Inhibitor)
Classification
Prescription Drug (Rx)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
076febd1aa35b5e5
Type
Standard
Back to Philippines FDA Approvals